Literature DB >> 18835028

Going with the flow: JAK-STAT signaling in JMML.

Demetrios Kalaitzidis1, D Gary Gilliland.   

Abstract

Knowledge of the distinctive cellular and genetic traits of a cancer aids in diagnosis, prognosis, and potentially treatment. In this issue of Cancer Cell, Kotecha et al. (2008) demonstrate using a sophisticated flow cytometry approach that signal transduction responses to exogenous stimulation can inform diagnosis and pathobiology of myeloproliferative neoplasms.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18835028     DOI： 10.1016/j.ccr.2008.09.006

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  4 in total

1.  Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia.

Authors:  Thomas Wilhelm; Daniel B Lipka; Tania Witte; Justyna A Wierzbinska; Silvia Fluhr; Monika Helf; Oliver Mücke; Rainer Claus; Carolin Konermann; Peter Nöllke; Charlotte M Niemeyer; Christian Flotho; Christoph Plass
Journal:  Epigenetics       Date:  2016-02-18       Impact factor: 4.528

2.  Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia.

Authors:  Jinyong Wang; Yangang Liu; Zeyang Li; Juan Du; Myung-Jeom Ryu; Philip R Taylor; Mark D Fleming; Ken H Young; Henry Pitot; Jing Zhang
Journal:  Blood       Date:  2010-10-04       Impact factor: 22.113

3.  A pediatric case of systemic lupus erythematosus developed 10 years after cord blood transplantation for juvenile myelomonocytic leukemia.

Authors:  Masayuki Nagasawa; Yuki Aoki
Journal:  Case Rep Transplant       Date:  2012-12-10

4.  GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia.

Authors:  Eric Padron; Jeffrey S Painter; Sateesh Kunigal; Adam W Mailloux; Kathy McGraw; Jessica M McDaniel; Eunhee Kim; Christopher Bebbington; Mark Baer; Geoffrey Yarranton; Jeffrey Lancet; Rami S Komrokji; Omar Abdel-Wahab; Alan F List; Pearlie K Epling-Burnette
Journal:  Blood       Date:  2013-04-30       Impact factor: 25.476
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.